Table 2.
CD29 | CD44 | CD166 | CD90 | CD73 | CD105 | STRO-1 | ||
---|---|---|---|---|---|---|---|---|
PCBM1641 | P3 | 99.9 | 94.3 | 99.8 | 98.9 | 99.8 | 99.9 | 10.8 |
P5 | 99.9 | 96.4 | 99.7 | 98.7 | 99.7 | 99.7 | 12.3 | |
P7 | 99.7 | 91.1 | 98.6 | 97.9 | 98.7 | 99.1 | 9.7 | |
PCBM1632 | P3 | 99.9 | 99.4 | 99.9 | 99.4 | 99.9 | 99.9 | 27.2 |
P5 | 99.9 | 99.3 | 99.5 | 99.7 | 99.5 | 99.5 | 17.1 | |
P7 | 99.5 | 95.5 | 98.7 | 97.7 | 96.6 | 96.6 | 12.6 |
The top row shows the antibodies used for multipotent stromal cell surface marker analysis by flow cytometry. The cell line designation and passage are shown in the first two columns on the left. Numbers show the percent positive cells for each of the indicated antibodies. MSC, multipotent stromal cells.